EASD 2020

2020-09-21 - 2020-09-25
Online, Virtual

EASD 2019

2019-09-16 - 2019-09-20
Barcelona, Spain

EASD 2018

2018-10-01 - 2018-10-05
Berlin, Germany

EASD 2017

2017-09-11 - 2017-09-15
Lisbon, Portugal

EASD 2016

2016-09-12 - 2016-09-16
Munich, Germany

ADA 2016

2016-06-10 - 2016-06-14
New Orleans, United States

EASD 2015

2015-09-14 - 2015-09-18
Stockholm, Sweden

ADA 2015

2015-06-05 - 2015-06-09
Boston, MA, United States

MDT EASD 2014

2014-11-20 - 2014-11-22
Budapest, Hungary
Search in Scientific Content:
Date
Filters:
Accumulate
8:58

Accumulated CV data from SGLT2i outcomes trials

Presenter: Darren McGuire
EASD 2020
Summary of
7:44

Summary of clinical and scientific topics discussed at EASD 2020 congress

Presenter: Stefano Del Prato
EASD 2020
Remission
10:22

Remission of type 2 diabetes with return of insulin secretory function restores normal pancreas morphology

Presenter: Roy Taylor
EASD 2020
Effects of
11:28

Effects of empagliflozin on physical activity and compensatory appetite responses in people with type 2 diabetes: the SEESAW trial

Presenter: Jack Sargeant
EASD 2020
Highlights
12:44

Highlights of the 2019 EASD Congress

Presenter: David R. Matthews
Specialty: Diabetes
EASD 2019
DAPA HF : ...
3:22

DAPA HF : The Dapagliflozin And Prevention Of Adverse‑ outcomes In Heart Failure Trial

Presenter: John McMurray
Specialty: Diabetes
EASD 2019
Early inte
10:09

Early intervention with oral semaglutide and long term safety

Presenter: Melanie Davies
Specialty: Diabetes
EASD 2019
VERIFY and
3:57

VERIFY and CONCLUDE study

Presenter: Stefano Del Prato
Specialty: Diabetes
EASD 2019
Cardio-ren
15:01

Cardio-renal risk

Presenter: Tina Vilsbøll
Specialty: Diabetes
EASD 2019
Clinical p
4:13

Clinical properties and differences between GLP-1 agonists

Presenter: Michael A. Nauck
Specialty: Diabetes
EASD 2019
Why We Sho
8:36

Why We Should Still Care about Glycemic Lowering Strategies for Type 2 Diabetes

Presenter: Hertzel Gerstein
Specialty: Diabetes
EASD 2019
Diabetic r
7:57

Diabetic retinopathy: Is the eye a mirror of the brain?

Presenter: Coen D.A. Stehouwer
Specialty: Diabetes
EASD 2019
Cardiovasc
3:32

Cardiovascular mode of action of GLP-1 receptor agonists

Presenter: Jorge Plutzky
Specialty: Diabetes
EASD 2018
Exploring
6:34

Exploring the effects of SGLT2 inhibition in ongoing clinical trials

Presenter: Stefan D. Anker
Specialty: Diabetes
EASD 2018
Cardiovasc
4:00

Cardiovascular outcome trials: putting recent updates into perspective

Presenter: Sanjay Rajagopalan
Specialty: Diabetes
EASD 2018
Clinical i
2:16

Clinical insights into recent EXAMINE trial data: an evolving story

Presenter: Robert Chilton
Specialty: Diabetes
EASD 2018
Medical De
9:40

Medical Devices in Diabetes

Presenter: Anne Louise Peters
Specialty: Diabetes
Will SGLT2
9:12

Will SGLT2-inhibitors change the landscape?

Presenter: Apostolos Tsapas
Specialty: Diabetes
Innate imm
10:54

Innate immunity in pancreatic islet inflammation

Presenter: Decio L. Eizirik
Specialty: Diabetes
The artifi
5:30

The artificial beta cell. When will the dream become reality?

Presenter: Eric Renard
Specialty: Diabetes
Observatio
6:15

Observational study of insulin pump treatment

Presenter: Soffia Gudbjörnsdottir
Specialty: Diabetes
The eviden
7:34

The evidence for metformin is unclear?

Presenter: Rury Holman
Specialty: Diabetes
The ORIGIN
10:10

The ORIGIN Study And Legacy Effects

Presenter: Hertzel Gerstein
Specialty: Diabetes
EMPA-REG O
11:11

EMPA-REG OUTCOME - a long-term, outcom study of empagliflozin in pateints with T2D at high CV risk

Presenter: Hans-Juergen Woerle
Specialty: Diabetes
Principal
10:00

Principal investigator presenting the results of EMPA-REG OUTCOME trial

Presenter: Bernard Zinman
Specialty: Diabetes
Joint Stat
4:28

Joint Statement on Diabetes Self-Management Education

Presenter: Martha Funnell
Specialty: Diabetes

Joint Statement on Diabetes Self-Management Education

Presenter: Melinda Maryniuk
Specialty: Diabetes

Joint Statement on Diabetes Self-Management Education

Presenter: Joan Bardsley
Specialty: Diabetes

50 years of clinical research in diabetes

Presenter: Daniel Porte
Specialty: Diabetes

50 years in treatment of diabetes complications

Presenter: Michael Brownlee
Specialty: Diabetes
50 years o
10:15

50 years of diabetes treatment

Presenter: Fred W. Whitehouse
Specialty: Diabetes

75 years with diabetes – a patient’s perspective

Presenter: M. Kathryn Ham
Specialty: Diabetes